A twice-yearly injection of Lenacapavir offers a 96% reduced risk of infection overall, making the injection significantly more effective than the daily oral PrEP...
With the injectable antiretroviral drug lenacapavir found to be “safe and 100% effective as long-acting HIV pre-exposure prophylaxis (PrEP) among cisgender women in a...
Even a modest increase in patient out-of-pocket costs for PrEP could result in a sharp increase in prescription abandonment—and a subsequent large increase in...
Forcing condomless sex was described by service providers as a way of asserting power or control over one's partner, and it has serious implications...